Patents by Inventor Guy Rouleu

Guy Rouleu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lafora's disease gene
    Patent number: 8486624
    Abstract: A novel gene (EPM2A) that is deleted or mutated in people with Lafora's disease is described. The EPM2A gene encodes a protein having an active catalytic site of a protein tyrosine phosphatase. Many different sequence mutations as well as several microdeletions in EPM2A have been found that co-segregate with Lafora's disease.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: July 16, 2013
    Assignees: The Hospital for Sick Children, McGill University, The Regents of the University of California, The United States of America, as represented by the Department of Veterans Affairs
    Inventors: Stephen W. Scherer, Berge A. Minassian, Antonio Delgado-Escueta, Guy Rouleu
  • Lafora's disease gene
    Publication number: 20100009346
    Abstract: A novel gene (EPMZA) that is deleted or mutated in people with Lafora's disease is described. The EPM2A gene encodes a protein having an active catalytic site of a protein tyrosine phosphatase. Many different sequence mutations as well as several microdeletions in EMP2A have been found that co-segregate with Lafora's disease.
    Type: Application
    Filed: October 31, 2007
    Publication date: January 14, 2010
    Inventors: Stephen W. Scherer, Berge A. Minassian, Antonio Delgado-Escueta, Guy Rouleu
  • Lafora's disease gene
    Patent number: 7550571
    Abstract: A novel gene (EPM2A) that is deleted or mutated in people with Lafora's disease is described. The EPM2A gene encodes a protein having an active catalytic site of a protein tyrosine phosphatase. Many different sequence mutations as well as several microdeletions in EPM2A have been found that co-segregate with Lafora's disease.
    Type: Grant
    Filed: July 8, 2004
    Date of Patent: June 23, 2009
    Assignees: McGrill University, The Hospital for Sick Children, The Regents of the University of California
    Inventors: Stephen W. Scherer, Berge A. Minassian, Antonio Delgado-Escueta, Guy Rouleu
  • Lafora's disease gene
    Publication number: 20040241740
    Abstract: A novel gene (EPM2A) that is deleted or mutated in people with Lafora's disease is described. The EPM2A gene encodes a protein having an active catalytic site of a protein tyrosine phosphatase. Many different sequence mutations as well as several microdeletions in EPM2A have been found that co-segregate with Lafora's disease.
    Type: Application
    Filed: July 8, 2004
    Publication date: December 2, 2004
    Inventors: Stephen W. Scherer, Berge A. Minassian, Antonio Delgado-Escueta, Guy Rouleu
  • Lafora's disease gene
    Patent number: 6825328
    Abstract: Lafora's disease in humans is characterized by the mutation or deletion of an EPM2A gene, which encodes a protein, Laforin, having a tyrosine phosphatase domain. Many different sequence mutations, including microdeletions, in EPM2A co-segregate with, Lafora's disease. Accordingly, detection of mutations in EPM2 are useful in diagnosing Lafora's disease.
    Type: Grant
    Filed: July 2, 2001
    Date of Patent: November 30, 2004
    Inventors: Stephen W. Scherer, Berge A. Minassian, Antonio Delgado-Escueta, Guy Rouleu